Literature DB >> 30954414

Improvement in arterial stiffness after short-term treatment with PCSK9 inhibitors.

A F G Cicero1, P P Toth2, F Fogacci3, A Virdis4, C Borghi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30954414     DOI： 10.1016/j.numecd.2019.01.010

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN： 0939-4753            Impact factor:   4.222


× No keyword cloud information.
  6 in total

Review 1.  From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis.

Authors:  D D'Ardes; F Santilli; M T Guagnano; M Bucci; F Cipollone
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-01-10

2.  Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis.

Authors:  Yue Wu; Ming-Jiang Xu; Zhiyou Cao; Chun Yang; Jinjie Wang; Bijue Wang; Jian Liu; Yuhui Wang; Xunde Xian; Fang Zhang; George Liu; Xiaoli Chen
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

3.  Acetylsalicylic Acid Reduces Passive Aortic Wall Stiffness and Cardiovascular Remodelling in a Mouse Model of Advanced Atherosclerosis.

Authors:  Lynn Roth; Miche Rombouts; Dorien M Schrijvers; Besa Emini Veseli; Wim Martinet; Guido R Y De Meyer
Journal:  Int J Mol Sci       Date:  2021-12-30       Impact factor: 5.923

Review 4.  PCSK9 Biology and Its Role in Atherothrombosis.

Authors:  Cristina Barale; Elena Melchionda; Alessandro Morotti; Isabella Russo
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

5.  Analysis of Arterial Stiffness and Sexual Function after Adding on PCSK9 Inhibitor Treatment in Male Patients with Familial Hypercholesterolemia: A Single Lipid Center Real-World Experience.

Authors:  Roberto Scicali; Giorgio Ivan Russo; Marina Di Mauro; Flavia Manuele; Grazia Di Marco; Antonino Di Pino; Viviana Ferrara; Agata Maria Rabuazzo; Salvatore Piro; Giuseppe Morgia; Francesco Purrello
Journal:  J Clin Med       Date:  2020-11-08       Impact factor: 4.241

Review 6.  Efficacy and safety of PCSK9 monoclonal antibodies: an evidence-based review and update.

Authors:  Rasha Kaddoura; Bassant Orabi; Amar M Salam
Journal:  J Drug Assess       Date:  2020-08-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.